Vaccinia virus is responsible for a zoonosis that usually affects cattle and human beings in Brazil. The initial clinical signs of the infection are focal red skin areas, fever, and general symptoms similar to those of a cold. Then, pustules and ulcerated lesions surrounded by edema and erythema follow, as well as local lymphadenopathy that can last for weeks. Cure and healing of the lesions occur over several weeks, leaving a typical scar in the skin of people and animals affected. The infection definitive diagnosis is made through morphological characterization of the virus by use of electron microscopy, followed by PCR for specific viral genes. Since 1963, circulating orthopoxviruses in infectious outbreaks in several regions of Brazil have been reported. Later, the etiological agent of those infections was characterized as samples of Vaccinia virus. In addition, the widespread use of those viruses in research laboratories and mass vaccination of militaries have contributed to increase the cases of those infections worldwide. Thus, several epidemiological and clinical studies are required, as well as studies of viral immunology, public health, and economic impact, because little is known about those Vaccinia virus outbreaks in Brazil.
Journal Information
Vol. 14. Issue 2.
Pages 129-134 (March - April 2010)
Vol. 14. Issue 2.
Pages 129-134 (March - April 2010)
Original article
Open Access
Clinical signs, diagnosis, and case reports of Vaccinia virus infections
Visits
2835
Daniela Carla Medeiros-Silva1,2, Eduardo Augusto dos Santos Moreira-Silva1,2,
, Juliana de Assis Silva Gomes1,3, Flávio Guimarães da Fonseca1,4, Rodrigo Correa-Oliveira1
Corresponding author
duduaugusto1@cpqrr.fiocruz.br
Correspondence to: Av. Dom Orione, 75 – São Luiz; Belo Horizonte – MG – Brazil CEP: 31310-020. Phone: 55 31 88079591.
Correspondence to: Av. Dom Orione, 75 – São Luiz; Belo Horizonte – MG – Brazil CEP: 31310-020. Phone: 55 31 88079591.
1 Centro de Pesquisas René Rachou (CPqRR), Fundação Oswaldo Cruz (Fiocruz), MG, Brazil, Ministério da Saúde
2 Department of Biochemistry and Immunology, Instituto de Ciências Biológicas (ICB), Universidade Federal de Minas Gerais (UFMG)
3 Department of Morphology, Instituto de Ciências Biológicas (ICB), Universidade Federal de Minas Gerais (UFMG)
4 Department of Microbiology, Biological Sciences Institute (ICB), Universidade Federal de Minas Gerais (UFMG)
This item has received
Article information
Abstract
Keywords:
Poxviridae infections
virology
outbreaks
zoonoses
Vaccinia virus
Full text is only aviable in PDF
References
[1]
B. Moss.
Poxviridae: the viruses and their replication.
Fields Virology, 4. ed.,
[2]
ICTVdB Management (2006). 00.058.1.01.001. Vaccinia virus. In: ICTVdB - The Universal Virus Database, version 4. Büchen-Osmond, C. (Ed), Columbia University, New York, USA, 2006.
[4]
R.C. Condit, N. Moussatche, P. Traktman.
In a nutshell: structure and assembly of the vaccinia virion.
Adv Virus Res, 66 (2006), pp. 31-124
[5]
F. Fenner, D.A. Henderson, I. Arita, Z. Jezek, I.D. Ladnyi.
Smallpox and its eradication.
World Health Organization, (1988),
[6]
S. Lewis-Jones.
Zoonotic poxvirus infections in humans.
Curr Opin Infect Dis., 17 (2004), pp. 81-89
[7]
K.D. Reed, J.W. Melski, M.B. Graham, et al.
The detection of monkeypox in humans in the Western Hemisphere.
N Engl J Med., 350 (2004), pp. 342-350
[8]
Centers for Disease Control and Prevention (CDC).
Multistate outbreak of monkeypox--Illinois, Indiana, and Wisconsin, 2003.
MMWR Morb Mortal Wkly Rep., 52 (2003), pp. 537-540
[9]
A.M. Likos, S.A. Sammons, V.A. Olson, et al.
A tale of two clades: monkeypox viruses.
J Gen Virol., 86 (2005), pp. 2661-2672
[10]
G.S. Trindade, Z.I. Lobato, B.P. Drumond, et al.
Short report: Isolation of two vaccinia virus strains from a single bovine vaccinia outbreak in rural area from Brazil: Implications on the emergence of zoonotic orthopoxviruses.
Am J Trop Med Hyg., 75 (2006), pp. 486-490
[11]
G. de Souza Trindade, F.G. da Fonseca, J.T. Marques, et al.
Araçatuba virus: a vaccinialike virus associated with infection in humans and cattle.
Emerg Infect Dis., 9 (2003), pp. 155-160
[12]
Centers for Disease Control, Prevention (CDC).
Laboratory-acquired vaccinia exposures and infections--United States, 2005-2007.
MMWR Morb Mortal Wkly Rep., 57 (2008), pp. 401-404
[13]
N. Moussatché, M. Tuyama, S.E. Kato, et al.
Accidental infection of laboratory worker with vaccinia virus.
Emerg Infect Dis., 9 (2003), pp. 724-726
[14]
M. Loeb, I. Zando, M.C. Orvidas, et al.
Laboratory-acquired vaccinia infection.
Can Commun Dis Rep., 29 (2003), pp. 134-136
[15]
C.G. Wlodaver, G.J. Palumbo, J.L. Waner.
Laboratory-acquired vaccinia infection.
J Clin Virol., 29 (2004), pp. 167-170
[16]
F.M. Lewis, E. Chernak, E. Goldman, et al.
Ocular vaccinia infection in laboratory worker, Philadelphia, 2004.
Emerg Infect Dis., 12 (2006), pp. 134-137
[17]
G. Hu, M.J. Wang, M.J. Miller, et al.
Ocular vaccinia following exposure to a smallpox vaccinee.
Am J Ophthalmol, 137 (2004), pp. 554-556
[18]
C. Egan, C.D. Kelly, K. Rush-Wilson, et al.
Laboratory-confirmed transmission of vaccinia virus infection through sexual contact with a military vaccinee.
J Clin Microbiol., 42 (2004), pp. 5409-5411
[19]
V.C. Andreev, J.M. Lachapelle, A.J. Rook.
An outbreak of accidental vaccinia in a family.
Dermatol Int., 8 (1969), pp. 5-9
[20]
D.C. Humphrey.
Localized accidental vaccinia infection of the vulva: report of 3 cases and a review of the world literature.
Am. J. Obstet. Gynecol., 86 (1963), pp. 460-469
[21]
J.M. Lane, V.A. Fulginiti.
Transmission of vaccinia virus and rationale for measures of prevention.
Clin Infect Dis., 37 (2003), pp. 281-284
[22]
C.E. Rupprecht, L. Blass, K. Smith, et al.
Human infection due to recombinant vaccinia-rabies glycoprotein virus.
N Engl J Med., 345 (2001), pp. 582-586
[23]
J.A. Leite, B.P. Drumond, G.S. Trindade, et al.
Passatempo virus, a vaccinia virus strain, Brazil.
Emerg Infect Dis., 11 (2005), pp. 1935-1938
[24]
G.S. Trindade, B.P. Drumond, M.I. Guedes, et al.
Zoonotic vaccinia virus infection in Brazil: clinical description and implications for health professionals.
J Clin Microbiol., 45 (2007), pp. 1370-1372
[25]
G.S. Trindade, M.I. Guedes, B.P. Drumond, et al.
Zoonotic Vaccinia Virus: Clinical and Immunological Characteristics in a Naturally Infected Patient.
Clin Infect Dis., 48 (2009), pp. 37-40
[26]
G.S. Trindade, G.L. Emerson, D.S. Carroll, E.G. Kroon, I.K. Damon.
Brazilian vaccinia viruses and their origins.
Emerg Infect Dis., 13 (2007), pp. 965-972
[27]
C.R. Damaso, J.J. Esposito, R.C. Condit, N. Moussatché.
An emergent Poxvirus from humans and cattle in Rio de Janeiro State: Cantagalo virus may derive from brazilian smallpox vaccine.
Virology, 277 (2000), pp. 439-449
[28]
F.G. Fonseca, M.C. Lanna, M.A. Campos, et al.
Morphological and molecular characterization of the poxvirus BeAn 58058.
Arch Virol., 143 (1998), pp. 1171-1186
[29]
F.G. da Fonseca, G.S. Trindade, R.L. Silva, et al.
Characterization of a vaccinia-like virus isolated in a Brazilian forest.
J Gen Virol., 83 (2002), pp. 223-228
[30]
H. Meyer, S.L. Ropp, J.J. Esposito.
Gene for A-type inclusion body protein is useful for a polymerase chain reaction assay to differentiate orthopoxviruses.
J Virol Methods, 64 (1997), pp. 217-221
[31]
G. de Souza Trindade, Y. Li, V.A. Olson, et al.
Real-time PCR assay to identify variants of Vaccinia virus: Implications for the diagnosis of bovine vaccinia in Brazil.
J Virol Methods, 152 (2008), pp. 63-71
[32]
H.G. Schatzmayr, E.R. Lemos, C. Mazur, et al.
Detection of poxvirus in cattle associated with human cases in the State of Rio de Janeiro: preliminary report.
Mem Inst Oswaldo Cruz., 95 (2000), pp. 625-627
[33]
Z.I.P. Lobato, G.S. Trindade, M.C.M. Frois, et al.
Surto de varíola bovina causada pelo vírus Vaccinia na região da Zona da Mata Mineira.
Arquivo Brasileiro de Medicina Veterinária e Zootecnia, 57 (2005), pp. 423-429
[34]
B.R. Simonetti, D.C. Abreu, J.P. Simonetti, et al.
Animal infections by vaccinia-like viruses in the state of Rio de Janeiro 1-North-western region.
Virus Reviews and Research, 12 (2007), pp. 32-36
[35]
J.T. Marques, G.D. Trindade, F.G. Da Fonseca, et al.
Characterization of ATI, TK and IFN-alpha/betaR genes in the genome of the BeAn 58058 virus, a naturally attenuated wild Orthopoxvirus.
Virus Genes., 23 (2001), pp. 291-301
[36]
O.S. Lopes, J.P. Lacerda, I.E. Fonseca, et al.
Cotia virus : a new agent isolated from sentinel mice in São Paulo, Brazil.
Am J Trop Med Hyg., 14 (1965), pp. 156-157
[37]
Y. Ueda, K.R. Dumbell, T. Tsuruhara, I. Tagaya.
Studies on Cotia virus an unclassified poxvirus.
J Gen Virol., 40 (1978), pp. 263-276
[38]
Y. Ueda, S. Morikawa, T. Watanabe.
Unclassified poxvirus: characterization and physical mapping of Cotia virus DNA and location of a sequence capable of encoding a thymidine kinase.
Virology, 210 (1995), pp. 67-72
[39]
J.J. Esposito, E.L. Palmer, E.C. Borden, Harrison, et al.
Studies on the poxvirus Cotia.
J Gen Virol., 47 (1980), pp. 37-46
[40]
C.R. Damaso, S.A. Reis, D.M. Jesus, P.S. Lima, N. Moussatché.
A PCR-based assay for detection of emerging vaccinia-like viruses isolated in Brazil.
Diagn Microbiol Infect Dis., 57 (2007), pp. 39-46
[41]
T.K. Nagasse-Sugahara, J.J. Kisielius, M. Ueda-Ito, et al.
Human vaccinia-like virus outbreaks in São Paulo and Goiás States, Brazil: virus detection, isolation and identification.
Rev Inst Med Trop Sao Paulo., 46 (2004), pp. 315-322
[42]
G.S. Trindade, F.G. da Fonseca, J.T. Marques, et al.
Belo Horizonte virus: a vaccinia-like virus lacking the A-type inclusion body gene isolated from infected mice.
J Gen Virol., 85 (2004), pp. 2015-2021
Copyright © 2010. Elsevier Editora Ltda.. All rights reserved